MedPath

A Single Arm Trial of Continuous 24-week-intervention with Designated Treatment Application for Essential Hypertension in addition to hypertension treatment in accordance with guideline

Not Applicable
Conditions
Essential Hypertension
Registration Number
JPRN-UMIN000035079
Lead Sponsor
CureApp, Inc.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with severe hypertension, a history of secondary hypertension, cardiovascular / cerebrovascular events, etc

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath